Halcion ליטא - ליטאית - SMCA (Valstybinė vaistų kontrolės tarnyba)

halcion

pfizer europe ma eeig - triazolamas - tabletės - 250 µg - triazolam

Lekoklar ליטא - ליטאית - SMCA (Valstybinė vaistų kontrolės tarnyba)

lekoklar

sandoz d.d. - klaritromicinas - plėvele dengtos tabletės - 500 mg - clarithromycin

Qinlock האיחוד האירופי - ליטאית - EMA (European Medicines Agency)

qinlock

deciphera pharmaceuticals (netherlands) b.v. - ripretinib - virškinimo trakto stromos navikai - antinavikiniai vaistai - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.

BiResp Spiromax האיחוד האירופי - ליטאית - EMA (European Medicines Agency)

biresp spiromax

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - vaistai nuo obstrukcinių kvėpavimo takų ligų, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

DuoResp Spiromax האיחוד האירופי - ליטאית - EMA (European Medicines Agency)

duoresp spiromax

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - vaistai nuo obstrukcinių kvėpavimo takų ligų, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

Astator ליטא - ליטאית - SMCA (Valstybinė vaistų kontrolės tarnyba)

astator

krka, d.d., novo mesto - atorvastatinas - plėvele dengtos tabletės - 80 mg; 60 mg; 30 mg - atorvastatin

Atoris ליטא - ליטאית - SMCA (Valstybinė vaistų kontrolės tarnyba)

atoris

krka, d.d., novo mesto - atorvastatinas - plėvele dengtos tabletės - 80 mg; 60 mg; 30 mg; 40 mg; 20 mg; 10 mg - atorvastatin

Atorvastatin Actavis ליטא - ליטאית - SMCA (Valstybinė vaistų kontrolės tarnyba)

atorvastatin actavis

actavis group ptc ehf. - atorvastatinas - plėvele dengtos tabletės - 80 mg; 20 mg; 10 mg; 40 mg - atorvastatin

Atorvastatin Polpharma ליטא - ליטאית - SMCA (Valstybinė vaistų kontrolės tarnyba)

atorvastatin polpharma

pharmaceutical works polpharma s.a. - atorvastatinas - plėvele dengtos tabletės - 40 mg; 20 mg; 10 mg - atorvastatin

Atorvastatin SUN ליטא - ליטאית - SMCA (Valstybinė vaistų kontrolės tarnyba)

atorvastatin sun

sun pharmaceutical industries europe b. v. - atorvastatinas - plėvele dengtos tabletės - 80 mg; 40 mg; 20 mg; 10 mg - atorvastatin